MyFinsight
Home
Blog
About
Effect of exchange rate
changes on cash and cash...
$454K
(11450.00%↑ Y/Y)
Net increase
(decrease) in cash and cash...
-$13,581K
(-628.20%↓ Y/Y)
Canceled cashflow
$454K
Net income (loss)
$3,777K
(209.32%↑ Y/Y)
Increase (decrease) in
accounts payable and...
$3,353K
(277.03%↑ Y/Y)
Financial expenses, net
-$571K
(-428.70%↓ Y/Y)
Depreciation
$406K
(-42.49%↓ Y/Y)
Share-based compensation
$398K
(-58.84%↓ Y/Y)
Changes in deferred
income tax asset
$71K
(-39.83%↓ Y/Y)
Changes in operating
lease right of use...
-$40K
(-205.26%↓ Y/Y)
Net cash provided by
(used in) operating...
-$10,400K
(-1.06%↓ Y/Y)
Net cash provided by
(used in) investing...
-$3,635K
(-384.67%↓ Y/Y)
Canceled cashflow
$8,616K
Increase in accounts
receivable-trade and other assets
$15,034K
(117.29%↑ Y/Y)
Investment in bank deposits
$3,000K
Purchase of property and
equipment
$593K
(-19.54%↓ Y/Y)
Amounts funded in
respect of employee...
$33K
(153.85%↑ Y/Y)
Increase in restricted
deposit
$9K
Increase in r&d grant
receivable
$2,100K
Decrease (increase) in
inventories
$1,818K
(1723.21%↑ Y/Y)
Changes in accrued
liability for employee...
-$64K
(-740.00%↓ Y/Y)
Back
Back
Cash Flow
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX)
source: myfinsight.com